Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cryoport Inc CYRX

Consumer Cyclical Technology Scientific & Technical Instruments Industrials
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its... see more

Recent & Breaking News (NDAQ:CYRX)

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors to Contact the Firm

Accesswire May 10, 2024

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors to Contact the Firm

Accesswire May 9, 2024

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors to Contact the Firm

Accesswire May 8, 2024

Cryoport Reports First Quarter 2024 Financial Results

PR Newswire May 7, 2024

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors to Contact the Firm

Accesswire May 7, 2024

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors to Contact the Firm

Accesswire May 6, 2024

Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024

PR Newswire April 30, 2024

Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results

PR Newswire March 12, 2024

Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

PR Newswire February 27, 2024

Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services

PR Newswire November 27, 2023

Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express

PR Newswire November 16, 2023

Cryoport Reports Third Quarter 2023 Financial Results

PR Newswire November 8, 2023

Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition

PR Newswire November 2, 2023

Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023

PR Newswire October 25, 2023

Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF

PR Newswire October 12, 2023

Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies

PR Newswire October 10, 2023

Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies

PR Newswire October 9, 2023

Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award

PR Newswire September 14, 2023

The Law Offices of Frank R. Cruz Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors

Business Wire September 12, 2023

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors

Business Wire September 11, 2023